Women's Health
Total Trials
12
As Lead Sponsor
11
As Collaborator
1
Total Enrollment
1,729
NCT03598088
Safety and Acceptability Study of a Non-Hormonal Ring
Phase: N/A
Role: Lead Sponsor
Start: May 23, 2018
Completion: Nov 15, 2019
NCT04370548
DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)
Phase: Phase 3
Start: Jun 16, 2020
Completion: Dec 7, 2020
NCT05418426
A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women
Phase: Phase 1
Start: Aug 18, 2020
Completion: Jan 27, 2022
NCT05354050
Pharmacokinetic Study of DARE-BV1
Start: Nov 3, 2020
Completion: Dec 2, 2020
NCT04948151
Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder
Phase: Phase 2
Role: Collaborator
Start: Jun 28, 2021
Completion: Dec 15, 2021
NCT05378269
Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA
Phase: Phase 1/2
Start: Nov 22, 2021
Completion: Mar 1, 2023
NCT05416255
Measuring Synovial Fluid Components
Start: Apr 1, 2022
Completion: Dec 31, 2024
NCT05367973
Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women
Start: Apr 11, 2022
Completion: Mar 23, 2023
NCT05765487
Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%
Start: May 13, 2023
Completion: Oct 21, 2024
NCT05752526
A Study of Diclofenac Gel in Women With Primary Dysmenorrhea
Start: May 19, 2023
Completion: Apr 26, 2024
NCT06127199
Contraceptive Efficacy Study of Ovaprene
Start: Dec 19, 2023
Completion: Sep 30, 2026
NCT06668896
Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
Start: Nov 30, 2025
Completion: Jun 30, 2026
Loading map...